MedTrace Logo

Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty

NCT00542516 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2009-02-19

No results posted yet for this study

Summary

Currently the most use solution to volemic reposition in hip replacement arthroplasty is the crystalloid solution. This trial intends to compare two different volemic replacements: HES and Ringer's lactate. This research has been analyzing hemodynamic parameters and the coagulation status before and after the pre-expansion with the solutions above mentioned.

Conditions

  • Hip Replacement Arthroplasty

Interventions

DRUG

Hydroxyethyl Starch

Dosage: 30ml/kg; frequency: one time; duration: 60min

DRUG

Ringer's lactate

Dosage: 30ml/kg; frequency: one time; duration: 60min.After 10ml-kg-h both groups

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • José Otávio C Auler Junior, PhD/Chairman · Hospital das Clínicas - Medicine School of the University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Completion
2008-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542516 on ClinicalTrials.gov